Stock Analysis

SEHK Value Picks DPC Dash And 2 Stocks That Investors Might Be Undervaluing

Published

As global markets navigate the complexities of rising oil prices and geopolitical tensions, Hong Kong's Hang Seng Index has shown resilience with a notable 10.2% gain in recent weeks. In this environment, identifying undervalued stocks can offer potential opportunities for investors looking to capitalize on market fluctuations and economic shifts.

Top 10 Undervalued Stocks Based On Cash Flows In Hong Kong

NameCurrent PriceFair Value (Est)Discount (Est)
Giant Biogene Holding (SEHK:2367)HK$50.85HK$97.5747.9%
MicroPort NeuroScientific (SEHK:2172)HK$9.97HK$18.9047.3%
Kuaishou Technology (SEHK:1024)HK$50.90HK$89.3243%
Yadea Group Holdings (SEHK:1585)HK$12.90HK$23.0244%
Semiconductor Manufacturing International (SEHK:981)HK$27.20HK$54.0349.7%
Shanghai INT Medical Instruments (SEHK:1501)HK$29.40HK$56.2047.7%
Hangzhou SF Intra-city Industrial (SEHK:9699)HK$11.08HK$19.7743.9%
CSC Financial (SEHK:6066)HK$10.08HK$17.8143.4%
Digital China Holdings (SEHK:861)HK$2.96HK$5.8249.1%
AK Medical Holdings (SEHK:1789)HK$4.74HK$8.3843.4%

Click here to see the full list of 36 stocks from our Undervalued SEHK Stocks Based On Cash Flows screener.

Here's a peek at a few of the choices from the screener.

DPC Dash (SEHK:1405)

Overview: DPC Dash Ltd, with a market cap of HK$10.33 billion, operates a chain of fast-food restaurants in the People’s Republic of China through its subsidiaries.

Operations: The company's revenue primarily comes from its fast-food restaurant operations in the People’s Republic of China, generating CN¥3.72 billion.

Estimated Discount To Fair Value: 41.5%

DPC Dash Ltd, recently added to the S&P Global BMI Index, demonstrates potential as an undervalued stock based on cash flows. The company reported half-year sales of CNY 2.04 billion, up from CNY 1.38 billion the previous year, with net income rising to CNY 10.91 million. Despite significant insider selling and a low forecasted return on equity of 8.4%, DPC Dash trades at HK$79.2, below its estimated fair value of HK$135.43 according to discounted cash flow analysis.

SEHK:1405 Discounted Cash Flow as at Oct 2024

Yunkang Group (SEHK:2325)

Overview: Yunkang Group Limited is a medical operation service provider in the People's Republic of China with a market cap of HK$5.39 billion.

Operations: The company generates revenue from its Diagnostic Services segment, which amounts to CN¥794.58 million.

Estimated Discount To Fair Value: 33.3%

Yunkang Group, despite recent challenges including a drop from the S&P Global BMI Index and reporting a net loss of CNY 126.13 million for the first half of 2024, is considered undervalued based on cash flow analysis. Trading at HK$9, below its estimated fair value of HK$13.49, it is forecasted to grow revenue by 10% annually and become profitable in three years, although its return on equity remains low at 2.5%.

SEHK:2325 Discounted Cash Flow as at Oct 2024

FIT Hon Teng (SEHK:6088)

Overview: FIT Hon Teng Limited manufactures and sells mobile and wireless devices and connectors in Taiwan and internationally, with a market cap of HK$19.77 billion.

Operations: The company's revenue is derived from two main segments: Consumer Products, which contributed $690.95 million, and Intermediate Products, which generated $3.94 billion.

Estimated Discount To Fair Value: 38.1%

FIT Hon Teng is trading at HK$2.79, significantly below its estimated fair value of HK$4.51, and analysts expect a 25.7% price increase. The company's revenue growth forecast of 18.4% annually outpaces the Hong Kong market average of 7.3%. Recent earnings showed a turnaround with USD 32.52 million in net income for H1 2024 compared to a prior net loss, although return on equity remains modest at an anticipated 10.9%.

SEHK:6088 Discounted Cash Flow as at Oct 2024

Turning Ideas Into Actions

Curious About Other Options?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com